Exploiting the pandemic for geopolitical gain.
A few good things will come out of the pandemic. A Democrat may well be the next US president and end the trade war with China, which will be in a better position to bargain, having had a lead in tackling the virus and a head start in economic recovery.
A group of neuroscience and neurotechnology researchers have conducted extensive research and developed a new brain imaging technology in two EU projects led by Aalto University. As a result of the successful research, a new project funded by Business Finland just started with the aim of making the devices usable for patients. The project’s budget is one million euros.
“More accurate measurements can be helpful in locating epileptic brain activity before surgery. The new device is also expected to help distinguish brain tumours from healthy tissue more accurately prior to cancer surgery. In addition, the device will increase our understanding of the connections between the different brain regions. This will help us understand abnormal brain activity in connection with, for example, depression or the progress of Alzheimer’s disease,” explains Professor Risto Ilmoniemi, Head of Aalto University Department of Neuroscience and Biomedical Engineering.
The improved accuracy can also be useful in the study of stroke, autism and brain injuries; and especially as part of basic brain research.
Media briefing on COVID-19 with Tedros Adhanom Ghebreyesus, Dr Mike Ryan and Dr Maria Van Kerkhove.
The increasing number of coronavirus cases in Italy has brought the entire country to a standstill. According to the Live Tracking Dashboard, there are 27,980 confirmed cases as of now and 2,158 people have succumbed to the infection. However, a total of 2,749 people have also recovered from the illness.
Since people are socially distancing themselves to avoid the virus from spreading, a lot of them are also losing business with every passing minute. There’s panic and tension all around. However, there is a piece of good news that’s become the silver lining at this time of misery.
Venice, one of Italy’s biggest tourist attractions, sees a lot of visitors throughout the year. However, ever since the country was put under lockdown, the streets are deserted and there is very less boat traffic on the city’s canals where people often enjoy the gondola rides. But surprisingly, the lockdown has helped in clearing the city’s canals. As reported By CNN, the locals have noticed a huge difference in the clarity of the water. The air quality has improved in the city.
Hope on the horizon:
1. Researcher make a breakthrough: Professor Katherine Kedzierska leads research at the Peter Doherty Institute for Infection and Immunity that discovers how the human body overcomes coronavirus.
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection.
Lead researcher Professor Kedzierska (Microbiology and Immunology) said the antibodies released by the human immune system to overcome coronavirus are very similar to those it uses to combat influenza — despite it never having being exposed to the disease.
A preprint of a study conducted by researchers from Utrecht University, in collaboration with Erasmus MC and Harbor BioMed, outlines the first report of a human monoclonal antibody that can block SARS-CoV-2.
Understanding antibodies: Terms and definitions
Antibodies are proteins that are produced by certain cells of the immune system known as B cells. They are able to bind to “foreign” material that tries to invade the body, such as pathogens, and directly neutralize them or trigger an immune response. This is achieved by binding of the antibody to an antigen, a specific molecule present on the pathogen.
Now, in an important new resource for the scientific community published today in Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center and New York University have developed a new kind of CRISPR screen technology to target RNA.
The researchers capitalized on a recently characterized CRISPR enzyme called Cas13 that targets RNA instead of DNA. Using Cas13, they engineered an optimized platform for massively-parallel genetic screens at the RNA level in human cells. This screening technology can be used to understand many aspects of RNA regulation and to identify the function of non-coding RNAs, which are RNA molecules that are produced but do not code for proteins.
By targeting thousands of different sites in human RNA transcripts, the researchers developed a machine learning-based predictive model to expedite identification of the most effective Cas13 guide RNAs. The new technology is available to researchers through an interactive website and open-source toolbox to predict guide RNA efficiencies for custom RNA targets and provides pre-designed guide RNAs for all human protein-coding genes.
SU COVID-19 summit | day 2